Preclinical dose response study shows NR2E3 can attenuate retinal degeneration in the retinitis pigmentosa mouse model RhoP23H+/−
Shannon M. McNamee(Massachusetts Eye and Ear Infirmary), Neena B. Haider(Massachusetts Eye and Ear Infirmary), Margaret M. DeAngelis(University at Buffalo, State University of New York), Kaden Nystuen(University of Massachusetts Amherst), Marielle O. Avola(Massachusetts Eye and Ear Infirmary), Natalie P. Chan(Massachusetts Eye and Ear Infirmary), Maiya Whalen(Massachusetts Eye and Ear Infirmary), Monica Akula(Massachusetts Eye and Ear Infirmary), Arun K. Upadhyay(Indian Institute of Technology Bhilai), Pushpendra Singh
Cited by 10
Related Papers
Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate
|Nature Genetics|2000|506
Alzheimer’s Disease: Models and Molecular Mechanisms Informing Disease and Treatments
|Bioengineering|2024|21
Evaluating therapeutic potential of NR2E3 doses in the rd7 mouse model of retinal degeneration
|Scientific Reports|2024|3